Clinical Trial Update: ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration [Phase 1]

View source ↗

Summary

Phase 1 study of ONL1204 Ophthalmic Solution for geographic atrophy associated with age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• ONL1204 Ophthalmic Solution

Snippet

Sponsor: ONL Therapeutics | Conditions: Geographic Atrophy | Phase 1 | Status: COMPLETED